504 related articles for article (PubMed ID: 9009089)
21. p53 may mediate the mdr-1 expression via the WT1 gene in human vincristine-resistant leukemia/lymphoma cell lines.
Hirose M; Kuroda Y
Cancer Lett; 1998 Jul; 129(2):165-71. PubMed ID: 9719458
[TBL] [Abstract][Full Text] [Related]
22. Temporal relationship of CDK1 activation and mitotic arrest to cytosolic accumulation of cytochrome C and caspase-3 activity during Taxol-induced apoptosis of human AML HL-60 cells.
Ibrado AM; Kim CN; Bhalla K
Leukemia; 1998 Dec; 12(12):1930-6. PubMed ID: 9844922
[TBL] [Abstract][Full Text] [Related]
23. Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients.
Ross DD; Doyle LA; Schiffer CA; Lee EJ; Grant CE; Cole SP; Deeley RG; Yang W; Tong Y
Leukemia; 1996 Jan; 10(1):48-55. PubMed ID: 8558937
[TBL] [Abstract][Full Text] [Related]
24. Treatment with inhibitors of caspases, that are substrates of drug transporters, selectively permits chemotherapy-induced apoptosis in multidrug-resistant cells but protects normal cells.
Blagosklonny MV
Leukemia; 2001 Jun; 15(6):936-41. PubMed ID: 11417480
[TBL] [Abstract][Full Text] [Related]
25. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
[TBL] [Abstract][Full Text] [Related]
26. Bcl-xL overexpression inhibits taxol-induced Yama protease activity and apoptosis.
Ibrado AM; Huang Y; Fang G; Bhalla K
Cell Growth Differ; 1996 Aug; 7(8):1087-94. PubMed ID: 8853905
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.
Ibrado AM; Huang Y; Fang G; Liu L; Bhalla K
Cancer Res; 1996 Oct; 56(20):4743-8. PubMed ID: 8840993
[TBL] [Abstract][Full Text] [Related]
28. Grape seed proanthocyanidin extract reverses multidrug resistance in HL-60/ADR cells via inhibition of the PI3K/Akt signaling pathway.
Lin KN; Jiang YL; Zhang SG; Huang SY; Li H
Biomed Pharmacother; 2020 May; 125():109885. PubMed ID: 32007917
[TBL] [Abstract][Full Text] [Related]
29. Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicin-resistant human K562 cell lines.
Grandjean F; Brémaud L; Verdier M; Robert J; Ratinaud MH
Anticancer Drugs; 2001 Mar; 12(3):247-58. PubMed ID: 11290872
[TBL] [Abstract][Full Text] [Related]
30. Reversing multidrug resistance in Caco-2 by silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL using liposomal antisense oligonucleotides.
Lo YL; Liu Y
PLoS One; 2014; 9(3):e90180. PubMed ID: 24637737
[TBL] [Abstract][Full Text] [Related]
31. Expression of the multidrug resistance-associated protein gene in refractory lymphoma: quantitation by a validated polymerase chain reaction assay.
Zhan Z; Sandor VA; Gamelin E; Regis J; Dickstein B; Wilson W; Fojo AT; Bates SE
Blood; 1997 May; 89(10):3795-800. PubMed ID: 9160686
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of SCN5A overcomes ABC transporter-mediated multidrug resistance in acute myeloid leukemia through promoting apoptosis.
Xu K; Zhuang XX; Shi XW
Expert Rev Hematol; 2024; 17(1-3):87-94. PubMed ID: 38230679
[TBL] [Abstract][Full Text] [Related]
33. Characterization of a human myeloid leukemia cell line highly resistant to taxol.
Bhalla K; Huang Y; Tang C; Self S; Ray S; Mahoney ME; Ponnathpur V; Tourkina E; Ibrado AM; Bullock G
Leukemia; 1994 Mar; 8(3):465-75. PubMed ID: 7907395
[TBL] [Abstract][Full Text] [Related]
34. Development and characterisation of novel human multidrug resistant mammary carcinoma lines in vitro and in vivo.
Stein U; Walther W; Lemm M; Naundorf H; Fichtner I
Int J Cancer; 1997 Sep; 72(5):885-91. PubMed ID: 9311609
[TBL] [Abstract][Full Text] [Related]
35. Molecular changes to HeLa cells on continuous exposure to cisplatin or paclitaxel.
Takara K; Obata Y; Yoshikawa E; Kitada N; Sakaeda T; Ohnishi N; Yokoyama T
Cancer Chemother Pharmacol; 2006 Dec; 58(6):785-93. PubMed ID: 16534613
[TBL] [Abstract][Full Text] [Related]
36. Double-edged sword of chemosensitizer: increase of multidrug resistance protein (MRP) in leukemic cells by an MRP inhibitor probenecid.
Kim HS; Min YD; Choi CH
Biochem Biophys Res Commun; 2001 Apr; 283(1):64-71. PubMed ID: 11322768
[TBL] [Abstract][Full Text] [Related]
37. Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia.
den Boer ML; Pieters R; Kazemier KM; Rottier MM; Zwaan CM; Kaspers GJ; Janka-Schaub G; Henze G; Creutzig U; Scheper RJ; Veerman AJ
Blood; 1998 Mar; 91(6):2092-8. PubMed ID: 9490695
[TBL] [Abstract][Full Text] [Related]
38. Functional expression of yeast artificial chromosome-human multidrug resistance genes in mouse cells.
Kusaba H; Kohno K; Asakuno K; Kuwano M; Okumura K; Green ED; Schlessinger D; Wada M
Genome Res; 1995 Oct; 5(3):245-58. PubMed ID: 8593612
[TBL] [Abstract][Full Text] [Related]
39. Two distinct modes of oncoprotein expression during apoptosis resistance in vincristine and daunorubicin multidrug-resistant HL60 cells.
Belhoussine R; Morjani H; Gillet R; Palissot V; Manfait M
Adv Exp Med Biol; 1999; 457():365-81. PubMed ID: 10500812
[TBL] [Abstract][Full Text] [Related]
40. Impact of the expression of P glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat shock protein 27 on response to induction therapy and long-term survival in patients with de novo acute myeloid leukemia.
Kasimir-Bauer S; Beelen D; Flasshove M; Noppeney R; Seeber S; Scheulen ME
Exp Hematol; 2002 Nov; 30(11):1302-8. PubMed ID: 12423683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
